NCT06703411View on ClinicalTrials.gov

Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)HospitalizationIron Deficiency

Interventions

DRUG

Iron Sucrose IV

IV iron sucrose 200mg per visit

DRUG

Standard Medical Therapy

Standard of care (HFrEF 4 pillars treatment)

Trial Locations (1)

112

Cheng Hsin General Hospital, Taipei

All Listed Sponsors

lead

Cheng-Hsin General Hospital

OTHER

NCT06703411 - Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency | Biotech Hunter | Biotech Hunter